We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04410991
Brief Title: Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)

First Submitted : May 28, 2020
First Submitted that Met QC Criteria : May 28, 2020
First Posted : June 1, 2020

Last Update Submitted that Met QC Criteria : August 5, 2022
Last Update Posted : August 8, 2022